BlackRock Health Sciences Trust (BME)
NYSE: BME · Real-Time Price · USD
39.34
+0.67 (1.73%)
Mar 23, 2026, 4:00 PM EDT - Market closed

BME Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
-0.05-0.03-0.04-0.08-0.08
Other Revenue
7.787.598.237.816.48
7.747.578.197.736.4
Revenue Growth (YoY)
2.23%-7.65%5.98%20.76%22.14%
Gross Profit
7.747.578.197.736.4
Selling, General & Admin
66.646.196.196.35
Operating Expenses
66.646.196.196.35
Operating Income
1.730.932.011.540.05
Interest Expense
-0-0-0--
Currency Exchange Gain (Loss)
0.02-0-0.01-0.01-0.01
Other Non Operating Income (Expenses)
-4.12-2.90.5510.12-9.75
EBT Excluding Unusual Items
-2.37-1.982.5511.64-9.7
Gain (Loss) on Sale of Investments
79.3425.4417.47-38.1168.83
Pretax Income
76.9723.4520.02-26.4759.13
Income Tax Expense
----0.01
Net Income
76.9723.4520.02-26.4759.12
Net Income to Common
76.9723.4520.02-26.4759.12
Net Income Growth
228.16%17.17%---25.69%
Shares Outstanding (Basic)
1313141413
Shares Outstanding (Diluted)
1313141413
Shares Change (YoY)
-2.50%-4.94%0.60%6.23%9.13%
EPS (Basic)
5.961.771.44-1.914.53
EPS (Diluted)
5.961.771.44-1.914.53
EPS Growth
236.57%23.26%---31.91%
Dividend Per Share
3.1452.6052.5562.5562.439
Dividend Growth
20.73%1.92%-4.80%1.63%
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
22.41%12.25%24.48%19.91%0.84%
Profit Margin
994.98%309.96%244.30%-342.40%923.46%
EBIT
1.730.932.011.540.05
EBIT Margin
22.41%12.25%24.48%19.91%0.84%
Effective Tax Rate
----0.02%
Revenue as Reported
7.747.578.197.736.4
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q